[EN] NOVEL P2X7R ANTAGONISTS AND THEIR USE<br/>[FR] NOUVEAUX ANTAGONISTES DE P2X7R ET LEUR UTILISATION
申请人:AFFECTIS PHARMACEUTICALS AG
公开号:WO2012163792A1
公开(公告)日:2012-12-06
The present application is directed to novel P2X7R antagonists that are lndol-3 carboxamide and azaindol-3 carboxamide compounds, pharmaceutical compositions comprising the same and their use for the prophylactic or therapeutic treatment of diseases mediated by P2X7R activity.
本申请涉及一种新型的P2X7R拮抗剂,它们是lndol-3羧酰胺和azaindol-3羧酰胺化合物,包括这些化合物的药物组合物以及它们用于预防或治疗由P2X7R活性介导的疾病的用途。